295 References 188. Crosbie PAJ, Shah R, Krysiak P, et al. Circulating tumor cells detected in the tumor-draining pulmonary vein are associated with disease recurrence after surgical resection of NSCLC. J Thorac Oncol. 2016;11(10):1793-1797. doi:10.1016/j.jtho.2016.06.017 189. Pechet TTV, Carr SR, Collins JE, Cohn HE, Farber JL. Arterial invasion predicts early mortality in stage I non-small cell lung cancer. Ann Thorac Surg. 2004;78(5):1748-1753. doi:10.1016/j.athoracsur.2004.04.061 190. Al-Alao BS, Gately K, Nicholson S, McGovern E, Young VK, O’Byrne KJ. Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Asian Cardiovasc Thorac Ann. 2014;22(1):55-64. doi:10.1177/0218492313478431 191. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients. Thorax. 2010;65(12):1092-1098. doi:10.1136/thx.2010.141861 192. Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 2011;24(12):1545-1552. doi:10.1038/modpathol.2011.119 193. Kryvenko ON, Epstein JI. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens. Am J Surg Pathol. 2012;36(12):1865-1873. doi:10.1097/PAS.0b013e318262c3d0 194. Leijssen LGJ, Dinaux AM, Amri R, et al. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. J Surg Oncol. 2019;119(6):749-757. doi:10.1002/jso.25367 195. Van Eeghen EE, Flens MJ, Mulder MMR, Loffeld RJLF. Extramural venous invasion as prognostic factor of recurrence in stage 1 and 2 colon cancer. Gastroenterol Res Pract. 2017;2017:1-6. doi:10.1155/2017/1598670 196. Metovic J, Falco EC, Vissio E, et al. Gross Specimen Handling Procedures Do Not Impact the Occurrence of Spread Through Air Spaces (STAS) in Lung Cancer. Am J Surg Pathol. 2021;45(2):215-222. doi:10.1097/PAS.0000000000001642 197. Blaauwgeers H, Thunnissen E. Spread Through Air Spaces (STAS): Can an Artifact Really be Excluded? Am J Surg Pathol. 2021;145(10):1439. doi:10.1097/PAS.0000000000001787 198. Radonic T, Dickhoff C, Mino-Kenudson M, Lely R, Paul R, Thunnissen E. Gross handling of pulmonary resection specimen: Maintaining the 3-dimensional orientation. J Thorac Dis. 2019;11(S1):S37-S44. doi:10.21037/jtd.2018.12.36 199. Gross DJ, Hsieh MS, Li Y, et al. Spread Through Air Spaces (STAS) in Non-Small Cell Lung Carcinoma: Evidence Supportive of an In Vivo Phenomenon. Am J Surg Pathol. 2021;45(11):1509-1515. doi:10.1097/PAS.0000000000001788 200. Eguchi T, Kameda K, Lu S, et al. Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2019;14(1):87-98. doi:10.1016/j.jtho.2018.09.005 201. Kadota K, Kushida Y, Kagawa S, et al. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces. Am J Surg Pathol. 2019;43(8):1033-1041. doi:10.1097/ PAS.0000000000001285 202. Ikeda T, Kadota K, Go T, Haba R, Yokomise H. Current status and perspectives of spread through air spaces in lung cancer. Thorac cancer. 2021;12(11):1639-1646. doi:10.1111/17597714.13918 203. Qi L, Xue K, Cai Y, Lu J, Li X, Li M. Predictors of CT Morphologic Features to Identify Spread Through Air Spaces Preoperatively in Small-Sized Lung Adenocarcinoma. Front Oncol. 2020;10:548430. doi:10.3389/fonc.2020.548430 A
RkJQdWJsaXNoZXIy MTk4NDMw